We only have this paper's title and publication details.
Read it at the sourceCase report demonstrates abrocitinib efficacy for treatment-resistant actinic prurigo in a pediatric patient, suggesting a novel targeted therapy for refractory photodermatoses.
No takes yet. Share an insight, caveat, or question.
Hoşgören-Tekin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: